Submissions from 2021
Identification of HU Window for Accurate Contouring of Metal Implants, Jen Yu, Andrew Wroe, and Alonso Gutierrez
Submissions from 2020
Multi-Institutional Experience Of Proton Beam Radiotherapy For Patients With Craniopharyngiomas, Haley Appel, Muni Rubens, Matthew Hall, Minesh Mehta, and Rupesh Kotecha
Multi-Institutional Experience of Proton Beam Radiotherapy for Pediatric Ependymomas, Haley Appel, Muni Rubens, Matthew Hall, Minesh Mehta, and Rupesh Kotecha
Tissue Oxygenation Changes in Response to Radiation Therapy in Breast Cancer Subjects Using Near-Infrared Optical Imaging, Corina Beiner, Maria-Amelia Rodrigues, and Michael Chuong
Psychosocial Support for Pediatric Patients at Proton Therapy Institutions, Nicole Boik and Matthew Hall
Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today, John Bryant, Michael Chuong, and Minesh Mehta
Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival, John Bryant, Michael Chuong, and Minesh Mehta
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient, John Bryant, Michael Chuong, and Minesh Mehta
Favorable Initial Outcomes of Abdominopelvic Reirradiation Using Dose-Escalated Magnetic Resonance Image-Guided Radiation Therapy, John Bryant, Kathryn Mittauer, Rupesh Kotecha, Jessika Contreras, Diane Alvarez, Noah Kalman, Matthew Hall, Gustavo Luciani, Tino Romaguera, Vivek Mishra, Minesh Mehta, Alonso Gutierrez, and Michael Chuong
Immunotherapy and radiation therapy for gastrointestinal malignancies: hope or hype?, Michael Chuong
Magnetic Resonance Guided Radiotherapy for Rectal Cancer: Expanding Opportunities for Non-Operative Management, Michael Chuong
Minimal acute toxicity from proton beam therapy for major salivary gland cancer, Michael Chuong
Proton beam therapy for liver cancers, Michael Chuong
Single-Fraction Stereotactic Body Radiation Therapy: A Paradigm During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond?, Michael Chuong
The Utility of PET/Computed Tomography for Radiation Oncology Planning, Surveillance, and Prognosis Prediction of Gastrointestinal Tumors, Michael Chuong
Case report of ablative magnetic resonance-guided stereotactic body radiation therapy for oligometastatic mesenteric lymph nodes from bladder cancer, Michael Chuong, Diane Alvarez, Tino Romaguera, Kathryn Mittauer, Sonia Adamson, Alonso Gutierrez, Gustavo Luciani, Hayden Guerrero Olmo, and Antonio Ucar
Ablative Dose Prescribed to Oligometastases Near Gastrointestinal Luminal Structures is Well Tolerated Using Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (SMART), Michael Chuong, Jessika Contreras, Rupesh Kotecha, Noah Kalman, Tino Romaguera, Alonso Gutierrez, Kathryn Mittauer, Diane Alvarez, Gustavo Luciani, and Matthew Hall
Median 50 Gy in 5 Consecutive Fractions Delivered with Stereotactic Magnetic Resonance Image-guided Radiation Therapy for Inoperable Pancreas Cancer, Michael Chuong, Rupesh Kotecha, Matthew Hall, Jessika Contreras, Kathryn Mittauer, Diane Alvarez, Tino Romaguera, Gustavo Luciani, Vivek Mishra, and Alonso Gutierrez
Radiotherapy and Late Effects, Matthew Hall
Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition, Matthew Hall and Minesh Mehta
Simulation of an HDR "Boost" with Stereotactic Proton versus Photon Therapy in Prostate Cancer: A Dosimetric Feasibility Study, Adeel Kaiser
Analyzing the role of adjuvant or salvage radiotherapy for spinal myxopapillary ependymomas, Rupesh Kotecha
Current approaches to the management of brain metastases, Rupesh Kotecha
Management of recurrent or progressive spinal metastases: reirradiation techniques and surgical principles, Rupesh Kotecha
Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery, Rupesh Kotecha
Impact of Radiotherapy Dosimetric Parameters on Neurocognitive Function in Brain Tumor Patients, Rupesh Kotecha and Matthew Hall
Extreme Hypofractionation for Newly Diagnosed Glioblastoma: Rationale, Dose, Techniques, and Outcomes, Rupesh Kotecha and Minesh Mehta
Stereotactic Radiosurgery for Non-Functioning Pituitary Adenomas: Meta-Analysis and International Society of Stereotactic Radiosurgery (ISRS) Practice Opinion, Rupesh Kotecha and Muni Rubens
Radiation therapy alone versus radiation therapy plus radiofrequency ablation/vertebral augmentation for spine metastasis: study protocol for a randomized controlled trial, Rupesh Kotecha, Brian Schiro, Justin Sporrer, Muni Rubens, Haley Appel, Kathleen Calienes, Belinda Boulanger, Marietsy Pujol, Deborah Suarez, Ashley Pena, Alex Kudryashev, and Minesh Mehta
Pulsed-reduced dose rate (PRDR) radiotherapy for recurrent primary central nervous system malignancies: dosimetric and clinical results, Tugce Kutuk, Alexander Mohler, Nicole McAllister, Matthew Hall, Martin Tom, Haley Appel, Ranjini Tolakanahalli, Alonso Gutierrez, Yazmin Odia, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
30. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL, Minesh Mehta
High-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539, Minesh Mehta
Investigating Low-Dose Thoracic Radiation as a Treatment for COVID-19 Patients to Prevent Respiratory Failure, Minesh Mehta
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?, Minesh Mehta
Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia, Minesh Mehta
Radiotherapy Innovations to Optimize Brain Metastases Control, Minesh Mehta
CTIM-15. PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA, Minesh Mehta, Rupesh Kotecha, and Yazmin Odia
CTNI-17. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA, Minesh Mehta, Yazmin Odia, Matthew Hall, and Doured Daghistani
HGG-18. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA, Minesh Mehta, Yazmin Odia, Matthew Hall, and Doured Daghistani
A Novel Pre-plan Technique for On-table Adaptation of Pancreatic Stereotactic MR-guided Online Adaptive Radiotherapy, Kathryn Mittauer, Michael Chuong, Jessika Contreras, Diane Alvarez, Tino Romaguera, Rupesh Kotecha, Matthew Hall, Minesh Mehta, and Alonso Gutierrez
DIPG-52. PHASE I CLINICAL TRIAL OF ONC201 IN PEDIATRIC H3 K27M-MUTANT GLIOMA OR NEWLY DIAGNOSED DIPG, Yazmin Odia, Matthew Hall, and Doured Daghistani
ONC201 in previously irradiated pediatric H3 K27M-mutant glioma or newly diagnosed DIPG, Yazmin Odia, Matthew Hall, and Doured Daghistani
Biological activity of weekly ONC201 in adult recurrent glioblastoma patients, Yazmin Odia and Minesh Mehta
Clinical experience of ONC201 in patients with recurrent H3 K27M-mutant spinal cord glioma, Yazmin Odia and Minesh Mehta
Early imaging marker of progressing glioblastoma: a window of opportunity, Yazmin Odia and Minesh Mehta
Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma, Yazmin Odia and Minesh Mehta
Design of a focused collimator for proton therapy spot scanning using Monte Carlo methods, Suresh Rana
Investigating beam matching for multi-room pencil beam scanning proton therapy, Suresh Rana and Jaafar Bennouna
Evaluation of spot size using volumetric repainting technique on a ProteusPLUS PBS Proton Therapy System, Suresh Rana, Jaafar Bennouna, and Alonso Gutierrez
Impact of magnetic field regulation in conjunction with the volumetric repainting technique on the spot positions and beam range in pencil beam scanning proton therapy, Suresh Rana, Jaafar Bennouna, and Alonso Gutierrez
Quantification of radiation and imaging isocenter coincidence of a multi-room PBS proton therapy system, Suresh Rana, Jaafar Bennouna, and Alonso Gutierrez
RADT-31. PATTERNS OF CARE IN THE USE OF ADJUVANT RADIOTHERAPY AND CHEMOTHERAPY IN LOW GRADE GLIOMA PATIENTS IN THE UNITED STATES FROM 2010-2016, Warren Rehrer, Yazmin Odia, Muni Rubens, Noah Kalman, Michael Chuong, Rupesh Kotecha, Minesh Mehta, and Matthew Hall
The Use of Adjuvant Radiotherapy and Chemotherapy in Low Grade Glioma Patients in the United States from 2010-2016, Warren Rehrer, Muni Rubens, Katherine Von Werne, Yazmin Odia, Michael Chuong, Rupesh Kotecha, Minesh Mehta, and Matthew Hall
Principles of Radiation Therapy in Breast Cancer, Maria-Amelia Rodrigues
Recent Health Care Expenditure Trends Among Adult Cancer Survivors in United States, 2009-2016, Muni Rubens, Anshul Saxena, Sankalp Das, Chintan Bhatt, Emir Veledar, Peter McGranaghan, Ana Viamonte Ros, Yuliya Linhares, Yazmin Odia, Michael Chuong, Rupesh Kotecha, and Minesh Mehta
Survival Impact Of Postoperative Radiotherapy Timing In Pediatric And Young Adult Ependymoma, Sunny Shah, Kevin Gates, Chase Mallory, Muni Rubens, Haley Appel, Noah Kalman, Rupesh Kotecha, Minesh Mehta, and Matthew Hall
Safety of Proton Therapy for Patients With Primary Central Nervous System Germinoma and Non-Germinomatous Germ Cell Tumors: Report from a Multi-Institutional Database Analysis, Katherine Von Werne, Melanie Naranjo, Haley Appel, Warren Rehrer, Muni Rubens, Michael Chuong, Minesh Mehta, Rupesh Kotecha, and Matthew Hall
Submissions from 2019
Prediction of Anal Cancer Recurrence After Chemoradiotherapy Using Quantitative Image Features Extracted From Serial (18)F-FDG PET/CT, Michael Chuong
Consensus Report From the Miami Liver Proton Therapy Conference, Michael Chuong and Alonso Gutierrez
Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA), Michael Chuong and Minesh Mehta
Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?, Michael Chuong and Minesh Mehta
EBV-positive primary CNS lymphoma restricted to the conus medullaris in an immunocompetent host, Matthew Hall, Lyle Feinstein, Sergio Gonzalez-Arias, and Yazmin Odia
First clinical experience with DRD2/3 antagonist ONC201 in H3 K27M-mutant pediatric diffuse intrinsic pontine glioma: a case report, Matthew Hall, Yazmin Odia, Doured Daghistani, and Minesh Mehta
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201, Matthew Hall, Yazmin Odia, and Minesh Mehta
CMET-06. AN ANALYSIS OF RESPONSE ENDPOINTS FOR BRAIN METASTASIS PATIENTS TREATED WITH STEREOTACTIC RADIOSURGERY AND PD(L)-1 INHIBITORS, Rupesh Kotecha
Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases, Rupesh Kotecha
Ten-year outcomes of moderately hypofractionated (70 Gy in 28 fractions) intensity modulated radiotherapy for localized prostate cancer, Rupesh Kotecha
The Impact of Sequencing PD-1/PD-L1 Inhibitors and Stereotactic Radiosurgery for Patients with Brain Metastasis, Rupesh Kotecha
The Complexity of Managing Large Brain Metastasis, Rupesh Kotecha and Minesh Mehta
Updates in the management of intradural spinal cord tumors: a radiation oncology focus, Rupesh Kotecha and Minesh Mehta
Barriers to Accrual and Enrollment in Brain Tumor Trials, Minesh Mehta
Comparison of Epidemiology and Outcomes in Neuro-Oncology Between the East and the West: Challenges and Opportunities, Minesh Mehta
Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis, Minesh Mehta
Letter: When Less is More: Dexamethasone Dosing for Brain Tumors, Minesh Mehta
Low-Grade Glioma Radiotherapy Treatment and Trials, Minesh Mehta
NRG brain tumor specialists consensus guidelines for glioblastoma contouring, Minesh Mehta
Preoperative Vs Postoperative Radiosurgery For Resected Brain Metastases: A Review, Minesh Mehta